Healthcare Latest news, Medical Technology Updated News
The newly developed and very smoothly and successfully running company dealing the matters concerning biotechnology that has been given the name Midatech Pharma also known as in abbreviated form PLC. This company basically deals with the research and development department…
Today, Vifor Pharma announced some changes in its management. Dr. Klaus Henning Jensen shall be welcomed by the company in January 2020 as their Chief Medical Officer as well as Member of the Executive Committee. The current Chief Commercial Officer…
Oregon Health & Science University (OHSU) has come up with another breakthrough invention as its scientists have developed a compound that encourages the repair of the nerve cell-protective myelin sheath that is damaged in diseases such as multiple sclerosis (MS).…
Emergency clinics and specialists endure Medicare’s low rates since they can take care of their expenses – and make a benefit – by charging private back up plans more. On the off chance that the whole populace is on Medicare’s…
Treatments which are based on evidence of efficacy & safety from clinical trials has been dominant for decades now in Europe & across the world. So, where is there still a continuity of one system of treatment which has been…
A clinical stage pharmaceutical development firm, Algernon Pharmaceuticals Inc. made an announcement that NP-120, its repurposed pioneering candidate to treat idiopathic pulmonary fibrosis, exhibited superiority in the reduction of fibrosis over two globally approved therapies for Nintedanib, idiopathic pulmonary fibrosis,…
Irish Pharmaceutical Healthcare Association has said that they should be reflecting on some version of the industry that will be inspiring hope for the health of humans rather than a narrative that is twisted by misconceptions and also narrow rows…
A prospectus has been filed for the Hong Kong IPO by the specialty pharma company, Tesla Biopharma. The anticipated transaction could raise around $1Bn. Tasly Bio is the biologics branch of Tasly Pharma, A TCM firm which decided in 2001…
The Switzerland-based pharma firm which focuses on the development of standard cancer care products, Helsinn, made an announcement today that Chief Operating Officer of the firm, Group General Manager, as well as, Giorgio Calderari have been appointed to the Board…
An announcement was made by the Santhera Pharmaceuticals that the Medicines & Healthcare products Regulatory Agency of the United Kingdom has renewed the Early Access to Medicines Scheme for another year for idebenone for those patients who have Duchenne muscular…